GLSI Greenwich LifeSciences, Inc.: institutional ownership and insider trading
60 funds reported holding $45.8M of Greenwich LifeSciences, Inc. in their latest 13F filings; in Q2 2026 funds net sold $608K, with 6 new positions and 11 funds selling out; over the last 12 months insiders bought $586K and sold $0 on the open market.
GLSI revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$3.95M, EPS -0.27
- Quarter ended Mar 31, 2026: revenue n/a, net income −$5.66M, EPS -0.39
- Quarter ended Dec 31, 2025: revenue n/a, net income −$9.15M, EPS -0.67
- Quarter ended Sep 30, 2025: revenue n/a, net income −$3.71M, EPS -0.27
Largest institutional holders of GLSI
- BlackRock, Inc. (BLK) — $11.4M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.53M
- VANGUARD GROUP INC — $6.23M
- GEODE CAPITAL MANAGEMENT, LLC — $3.95M
- STATE STREET CORP (STT, STT-PG) — $3.36M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $1.90M
- NORTHERN TRUST CORP (NTRS, NTRSO) — $1.88M
- Bank of New York Mellon Corp (BK, BK-PK) — $1.12M
- VANGUARD FIDUCIARY TRUST CO — $1.08M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $1.02M
Recent GLSI insider trades
- Jul 29, 2026: Patel Snehal bought 2,200 shares ($29.6K)
- Jul 27, 2026: Patel Snehal bought 1,500 shares ($20.4K)
- Jul 24, 2026: Patel Snehal bought 3,600 shares ($47.0K)
- Jan 13, 2026: Patel Snehal bought 1,800 shares ($53.7K)
Who owns the most GLSI stock?
The largest institutional holders of Greenwich LifeSciences, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($11.4M), VANGUARD CAPITAL MANAGEMENT LLC ($6.53M), VANGUARD GROUP INC ($6.23M).
Are insiders buying or selling GLSI?
Over the last 12 months insiders bought $586K and sold $0 of Greenwich LifeSciences, Inc. stock on the open market (SEC Form 4).